Cite
HARVARD Citation
Marian, M. et al. (2017). Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention. Journal of the American Heart Association. 6 (6), p. n/a. [Online].